Methods for determining whether a compound alters the amount of at least one αβ (X-41) peptide and the amount of either total αβ or at least one αβ (X-40) peptide produced by a non-human mammal

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7993627
APP PUB NO 20030148392A1
SERIAL NO

10335035

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention provides methods of screening compounds for their ability to alter the production of Aβ(x≧41) alone or in combination with Aβ(x≦40). The methods involve administering compounds to cells, specifically measuring the amounts of Aβ(x≦40) and Aβ(x≧41) produced by the cells, and comparing these amounts to that produced by the cells without administration of the compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;ELAN PHARMACEUTICALS, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Citron, Martin Thousand Oaks, US 6 80
Schenk, Dale B Burlingame, US 133 5575
Selkoe, Dennis J Jamaica Plain, US 12 504
Seubert, Peter A San Francisco, US 33 1388

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation